TargetCoat®: Premium Pharmaceutical Polymers by H Jules & Company Limited
TargetCoat® is a registered trademark of H Jules & Company Limited, representing a range of pharmaceutical film-coating polymers designed to optimize drug delivery.
TargetCoat® L100
(Methacrylic Acid and Methyl Methacrylate Copolymer (1:1))
Key Features:
- Protects active pharmaceutical ingredients (APIs)
- Enhances drug product effectiveness
- Reduces formulation risk
- Low viscosity for easier processing during manufacturing
- High pigment binding capacity
- Excellent film adhesion for improved dosage form stability
TargetCoat® L30D55
(Methacrylic Acid and Ethyl Acrylate Copolymer Dispersion)
Key Features:
- Specifically designed for controlled-release applications
- Combines the benefits of methacrylic acid and ethyl acrylate
- Provides sustained drug release profiles
- Ideal for extended-release tablets and capsules,
TargetCoat® NM30D
(Ethyl Acrylate and Methyl Methacrylate Copolymer)
Key Features:
- Offers a unique balance between solubility and controlled release
- Modifies drug release rates
- Improves bioavailability
- Enhances patient compliance
Ongoing Developments
H Jules & Company Limited is establishing its footprint in the pharmaceutical polymer industry. Our team is continuously developing new copolymers to address specific formulation challenges and meet patient needs. For example, we are currently working on a novel polymer with enhanced gastric stability for targeted drug delivery to the intestines.